Harlequin Fetus
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Harlequin Fetus
|
0.900 |
Biomarker
|
disease |
BEFREE |
We confirmed that ABCA12 defects cause congested lipid secretion in cultured HI keratinocytes and succeeded in obtaining the recovery of LG lipid secretion after corrective gene transfer of ABCA12.
|
16007253 |
2005 |
Harlequin Fetus
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Sequencing of the ABCA12 gene, which maps within the minimal region defined by homozygosity mapping, revealed disease-associated mutations, including large intragenic deletions and frameshift deletions in 11 of the 12 screened individuals with HI.
|
15756637 |
2005 |
Harlequin Fetus
|
0.900 |
Biomarker
|
disease |
BEFREE |
Recently, mutations in two ABC-transporter genes, ABCC6 and ABCA12, have been demonstrated to underlie phenotypically different diseases affecting the skin (pseudoxanthoma elasticum and harlequin ichthyosis, respectively), attesting to the spectrum of ABC gene mutations in human diseases.
|
15996518 |
2005 |
Harlequin Fetus
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Recently, ABCA12 mutations were identified as the cause of HI.
|
16675967 |
2006 |
Harlequin Fetus
|
0.900 |
Biomarker
|
disease |
BEFREE |
Harlequin ichthyosis is caused by a serious functional deficiency of ABCA12.
|
16847209 |
2006 |
Harlequin Fetus
|
0.900 |
Biomarker
|
disease |
CTD_human |
Recently, ABCA12 mutations were identified as the cause of HI.
|
16675967 |
2006 |
Harlequin Fetus
|
0.900 |
Biomarker
|
disease |
BEFREE |
One of these components, ABCA12, has recently been shown to be a keratinocyte lipid transporter associated with lipid transport in lamellar granules and loss of ABCA12 function leads to a defective lipid barrier in the stratum corneum, resulting in the HI phenotype.
|
16481150 |
2006 |
Harlequin Fetus
|
0.900 |
AlteredExpression
|
disease |
BEFREE |
This report provides evidence for residual ABCA12 expression in HI, and demonstrates the efficiency of early DNA-based PD of HI.
|
17082782 |
2007 |
Harlequin Fetus
|
0.900 |
AlteredExpression
|
disease |
BEFREE |
The present patient demonstrates that rapid diagnosis of HI by ABCA12 expression analysis and mutation detection, and early commencement of systemic retinoid therapy are crucial to significantly improving an HI patient's prognosis.
|
17684380 |
2007 |
Harlequin Fetus
|
0.900 |
Biomarker
|
disease |
BEFREE |
Abca12(-/-) mice closely reproduce the human HI phenotype, showing marked hyperkeratosis with eclabium and skin fissure.
|
18632686 |
2008 |
Harlequin Fetus
|
0.900 |
Biomarker
|
disease |
BEFREE |
Until the identification of ABCA12 as the causative gene, prenatal diagnosis (PND) for HI had been performed by electronmicroscopic observation of fetal skin biopsy samples.
|
18262308 |
2008 |
Harlequin Fetus
|
0.900 |
Biomarker
|
disease |
MGD |
Mutations in the gene encoding a member of the ABCA transporter family, ABCA12, have been linked to harlequin ichthyosis, but the molecular function of the protein is unknown.
|
18957418 |
2008 |
Harlequin Fetus
|
0.900 |
Biomarker
|
disease |
MGD |
Abca12(-/-) mice closely reproduce the human HI phenotype, showing marked hyperkeratosis with eclabium and skin fissure.
|
18632686 |
2008 |
Harlequin Fetus
|
0.900 |
Biomarker
|
disease |
BEFREE |
A mouse model of harlequin ichthyosis delineates a key role for Abca12 in lipid homeostasis.
|
18802465 |
2008 |
Harlequin Fetus
|
0.900 |
Biomarker
|
disease |
BEFREE |
In fact, loss of ABCA12 function leads to a defective lipid barrier in the stratum corneum, resulting in the HI phenotype and ABCA12 is a known keratinocyte lipid transporter associated with lipid transport in lamellar granules.
|
18341575 |
2008 |
Harlequin Fetus
|
0.900 |
Biomarker
|
disease |
MGD |
A mouse model of harlequin ichthyosis delineates a key role for Abca12 in lipid homeostasis.
|
18802465 |
2008 |
Harlequin Fetus
|
0.900 |
AlteredExpression
|
disease |
BEFREE |
As seen in HI epidermis, proteins that are normally expressed in late differentiation were highly dysregulated in the ABCA12-ablated OTCC system.
|
19179616 |
2009 |
Harlequin Fetus
|
0.900 |
GermlineCausalMutation
|
disease |
ORPHANET |
As seen in HI epidermis, proteins that are normally expressed in late differentiation were highly dysregulated in the ABCA12-ablated OTCC system.
|
19179616 |
2009 |
Harlequin Fetus
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Trisomic rescue causing reduction to homozygosity for a novel ABCA12 mutation in harlequin ichthyosis.
|
19664001 |
2009 |
Harlequin Fetus
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Mutations in ABCA12 have been described in autosomal recessive congenital ichthyoses (ARCI) including harlequin ichthyosis (HI), congenital ichthyosiform erythroderma (CIE), and lamellar ichthyosis (LI).HI shows the most severe phenotype.
|
20672373 |
2010 |
Harlequin Fetus
|
0.900 |
Biomarker
|
disease |
BEFREE |
Self-improvement of keratinocyte differentiation defects during skin maturation in ABCA12-deficient harlequin ichthyosis model mice.
|
20489143 |
2010 |
Harlequin Fetus
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Patients with harlequin ichthyosis for whom we had performed ABCA12 mutation analysis.
|
21339420 |
2011 |
Harlequin Fetus
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
A Mutations in the gene encoding the ABCA12 protein are associated with different subtypes of autosomal recessive congenital ichthyosis (ARCI), including Harlequin ichthyosis (HI), lamellar ichthyosis (LI) and non-bullous congenital ichthyosiform erythroderma (NCIE).
|
22257947 |
2012 |
Harlequin Fetus
|
0.900 |
Biomarker
|
disease |
BEFREE |
This article reviews current opinions on the patho-mechanisms of ABCA12 action in HI and potential therapeutic interventions based on targeted molecular therapy and gene therapy strategies.
|
22864982 |
2013 |